Skip to main content
. 2011 May 17;104(12):1822–1827. doi: 10.1038/bjc.2011.154

Table 2. Number of patients with grade 3/4 adverse events considered to be related to study treatment.

Adverse event Grade 3 Grade 4
Neutropaenia 1 0
Lymphopaenia 22 0
Thrombocytopaenia 1 0
Anaemia 2 1
Fatigue 11 0
Neurological 6 0
Lethargy 3 0
Diarrhoea 3 0
Dyspnoea 1 0
Vomiting 1 1
Malaise 1 0
Indigestion 1 0
Ischaemic attack 1 0